세계의 브로멜라인 시장 성장, 규모, 동향 분석 : 형태별, 용도별 - 지역별 전망, 경쟁 전략, 부문 예측(-2034년)

Bromelain Market Introduction and Overview

According to SPER Market Research, 'Global Bromelain Market Size- By Form, By Application- Regional Outlook, Competitive Strategies and Segment Forecast to 2034' the Global Bromelain Market is estimated to reach USD 56.24 million by 2034 with a CAGR of 6.94%.

Bromelain is a naturally occurring enzyme found in pineapple stems and fruits. It aids in protein breakdown, making it effective for purposes such as meat tenderisation, digestive support, and inflammation reduction. Because of its medicinal and functional properties, bromelain is widely utilised in supplements, pharmaceuticals, cosmetic products, and the food and beverage industry.

Restraints: Despite its growing use, the bromelain market faces several challenges. The primary issue is that bromelain is sourced from pineapples, which are affected by seasonal and environmental factors, leading to unstable supply and pricing. The process of extracting and purifying bromelain is also time-consuming and expensive, limiting production scalability for smaller companies.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Form, By Application

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered Advanced Enzymes, Biozyme Laboratories, Creative Enzymes, Digestive Enzymes International, Enzybel International, Enzyme Development, Hong Mao Biochemicals, Integrative Therapeutics, Mountain Fresh, Nanning Doing-Higher Bio-Tech, Nanning Pangbo Biological Engineering.

Global Bromelain Market Segmentation:

By Form: Based on the Form, Global Bromelain Market is segmented as; Powder, Liquid, Others

By Application: Based on the Application, Global Bromelain Market is segmented as; Food & beverages, Nutraceuticals, Pharmaceuticals, Cosmetics & personal care, Others

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

1. Introduction

• 1.1. Scope of the report
• 1.2. Market segment analysis

2. Research Methodology

• 2.1. Research data source
  • 2.1.1. Secondary Data
  • 2.1.2. Primary Data
  • 2.1.3. SPERs internal database
  • 2.1.4. Premium insight from KOLs
• 2.2. Market size estimation
  • 2.2.1. Top-down and Bottom-up approach
• 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

• 4.1. Driver, Restraint, Opportunity and Challenges analysis
  • 4.1.1. Drivers
  • 4.1.2. Restraints
  • 4.1.3. Opportunities
  • 4.1.4. Challenges

5. Market variable and outlook

• 5.1. SWOT Analysis
  • 5.1.1. Strengths
  • 5.1.2. Weaknesses
  • 5.1.3. Opportunities
  • 5.1.4. Threats
• 5.2. PESTEL Analysis
  • 5.2.1. Political Landscape
  • 5.2.2. Economic Landscape
  • 5.2.3. Social Landscape
  • 5.2.4. Technological Landscape
  • 5.2.5. Environmental Landscape
  • 5.2.6. Legal Landscape
• 5.3. PORTERs Five Forces
  • 5.3.1. Bargaining power of suppliers
  • 5.3.2. Bargaining power of buyers
  • 5.3.3. Threat of Substitute
  • 5.3.4. Threat of new entrant
  • 5.3.5. Competitive rivalry
• 5.4. Heat Map Analysis

6. Competitive Landscape

• 6.1. Global Bromelain Market Manufacturing Base Distribution, Sales Area, Product Type
• 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Bromelain Market

7. Global Bromelain Market, By Form (USD Million) 2021-2034

• 7.1. Powder
• 7.2. Liquid
• 7.3. Others

8. Global Bromelain Market, By Application (USD Million) 2021-2034

• 8.1. Food & beverages
• 8.2. Nutraceuticals
• 8.3. Pharmaceuticals
• 8.4. Cosmetics & personal care
• 8.5. Others

9. Global Bromelain Market, (USD Million) 2021-2034

• 9.1. Global Bromelain Market Size and Market Share

10. Global Bromelain Market, By Region, (USD Million) 2021-2034

• 10.1. Asia-Pacific
  • 10.1.1. Australia
  • 10.1.2. China
  • 10.1.3. India
  • 10.1.4. Japan
  • 10.1.5. South Korea
  • 10.1.6. Rest of Asia-Pacific
• 10.2. Europe
  • 10.2.1. France
  • 10.2.2. Germany
  • 10.2.3. Italy
  • 10.2.4. Spain
  • 10.2.5. United Kingdom
  • 10.2.6. Rest of Europe
• 10.3. Middle East and Africa
  • 10.3.1. Kingdom of Saudi Arabia
  • 10.3.2. United Arab Emirates
  • 10.3.3. Qatar
  • 10.3.4. South Africa
  • 10.3.5. Egypt
  • 10.3.6. Morocco
  • 10.3.7. Nigeria
  • 10.3.8. Rest of Middle-East and Africa
• 10.4. North America
  • 10.4.1. Canada
  • 10.4.2. Mexico
  • 10.4.3. United States
• 10.5. Latin America
  • 10.5.1. Argentina
  • 10.5.2. Brazil
  • 10.5.3. Rest of Latin America

11. Company Profile

• 11.1. Advanced Enzymes
  • 11.1.1. Company details
  • 11.1.2. Financial outlook
  • 11.1.3. Product summary
  • 11.1.4. Recent developments
• 11.2. Biozyme Laboratories
  • 11.2.1. Company details
  • 11.2.2. Financial outlook
  • 11.2.3. Product summary
  • 11.2.4. Recent developments
• 11.3. Creative Enzymes
  • 11.3.1. Company details
  • 11.3.2. Financial outlook
  • 11.3.3. Product summary
  • 11.3.4. Recent developments
• 11.4. Digestive Enzymes International
  • 11.4.1. Company details
  • 11.4.2. Financial outlook
  • 11.4.3. Product summary
  • 11.4.4. Recent developments
• 11.5. Enzyme Development
  • 11.5.1. Company details
  • 11.5.2. Financial outlook
  • 11.5.3. Product summary
  • 11.5.4. Recent developments
• 11.6. Hong Mao Biochemicals
  • 11.6.1. Company details
  • 11.6.2. Financial outlook
  • 11.6.3. Product summary
  • 11.6.4. Recent developments
• 11.7. Integrative Therapeutics
  • 11.7.1. Company details
  • 11.7.2. Financial outlook
  • 11.7.3. Product summary
  • 11.7.4. Recent developments
• 11.8. Mountain Fresh
  • 11.8.1. Company details
  • 11.8.2. Financial outlook
  • 11.8.3. Product summary
  • 11.8.4. Recent developments
• 11.9. Nanning Doing-Higher Bio-Tech
  • 11.9.1. Company details
  • 11.9.2. Financial outlook
  • 11.9.3. Product summary
  • 11.9.4. Recent developments
• 11.10. Others

12. Conclusion

13. List of Abbreviations

14. Reference Links